Randomized, Open-label, SU-controlled Study of 24-week Duration to Compare Metformin/Vildagliptin + Basal Insulin Versus Metformin/SU + Basal Insulin in T2DM Patients Starting Basal Insulin After Failing Metformin/SU
Phase of Trial: Phase III
Latest Information Update: 14 Nov 2017
At a glance
- Drugs Vildagliptin (Primary) ; Insulin; Metformin; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Acronyms ADDONIS
- Sponsors Novartis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 06 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jan 2015 Planned End Date changed from 1 Oct 2014 to 1 Feb 2015 as reported by ClinicalTrials.gov record.